Search results for "Drug profile"

showing 1 items of 1 documents

Lurasidone in the Treatment of Bipolar Depression: Systematic Review of Systematic Reviews

2017

Introduction. A burgeoning number of systematic reviews considering lurasidone in the treatment of bipolar depression have occurred since its Food and Drug Administration extended approval in 2013. While a paucity of available quantitative evidence still precludes preliminary meta-analysis on the matter, the present quality assessment of systematic review of systematic reviews, nonetheless, aims at highlighting current essential information on the topic. Methods. Both published and unpublished systematic reviews about lurasidone mono- or adjunctive therapy in the treatment of bipolar depression were searched by two independent authors inquiring PubMed/Cochrane/Embase/Scopus from inception u…

Genetics and Molecular Biology (all)Transtorno Bipolarmedicine.medical_specialtyBipolar DisorderImmunology and Microbiology (all)ConcordanceDrug profileAlternative medicineMEDLINElcsh:MedicineReview ArticleBiochemistryGeneral Biochemistry Genetics and Molecular Biology03 medical and health sciencesLurasidone Hydrochloride0302 clinical medicineImmunology and Microbiology (all); Biochemistry Genetics and Molecular Biology (all)medicineBipolar DepressionHumansPsychiatryDrug ApprovalDepression (differential diagnoses)LurasidoneGeneral Immunology and Microbiologybusiness.industrylcsh:RGeneral Medicine030227 psychiatrySystematic reviewTolerabilityDepressãobusiness030217 neurology & neurosurgerymedicine.drugLurasidone
researchProduct